Literature DB >> 23544265

The regulation of sleep and wakefulness by the hypothalamic neuropeptide orexin/hypocretin.

Ayumu Inutsuka1, Akihiro Yamanaka.   

Abstract

Orexins, also known as hypocretins, are neuropeptides that are exclusively expressed by neurons in the lateral hypothalamic area. Although originally recognized as regulators of feeding behavior, orexins are now mainly regarded as key modulators of the sleep/wakefulness cycle. In addition, anatomical studies of neural networks and analyses of transgenic mice have revealed integrated roles for orexin neurons in the coordination of emotion, energy homeostasis, and the reward system. A functional link between the limbic system and orexin neurons may be important for increasing vigilance in response to emotional stimuli. These findings suggest that orexin neurons relay information about an organism's environment to maintain the proper amount of sleep and wakefulness in animals.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23544265      PMCID: PMC4345701     

Source DB:  PubMed          Journal:  Nagoya J Med Sci        ISSN: 0027-7622            Impact factor:   1.131


  47 in total

1.  Sleep homeostasis modulates hypocretin-mediated sleep-to-wake transitions.

Authors:  Matthew E Carter; Antoine Adamantidis; Hiroshi Ohtsu; Karl Deisseroth; Luis de Lecea
Journal:  J Neurosci       Date:  2009-09-02       Impact factor: 6.167

2.  Discharge properties of presumed cholinergic and noncholinergic laterodorsal tegmental neurons related to cortical activation in non-anesthetized mice.

Authors:  K Sakai
Journal:  Neuroscience       Date:  2012-08-21       Impact factor: 3.590

Review 3.  Orexin links emotional stress to autonomic functions.

Authors:  Tomoyuki Kuwaki
Journal:  Auton Neurosci       Date:  2010-09-01       Impact factor: 3.145

4.  Acute optogenetic silencing of orexin/hypocretin neurons induces slow-wave sleep in mice.

Authors:  Tomomi Tsunematsu; Thomas S Kilduff; Edward S Boyden; Satoru Takahashi; Makoto Tominaga; Akihiro Yamanaka
Journal:  J Neurosci       Date:  2011-07-20       Impact factor: 6.167

5.  Regulation of adaptive behaviour during fasting by hypothalamic Foxa2.

Authors:  Jose P Silva; Ferdinand von Meyenn; Jessica Howell; Bernard Thorens; Christian Wolfrum; Markus Stoffel
Journal:  Nature       Date:  2009-12-03       Impact factor: 49.962

6.  Neural substrates of awakening probed with optogenetic control of hypocretin neurons.

Authors:  Antoine R Adamantidis; Feng Zhang; Alexander M Aravanis; Karl Deisseroth; Luis de Lecea
Journal:  Nature       Date:  2007-10-17       Impact factor: 49.962

7.  Differential roles of orexin receptor-1 and -2 in the regulation of non-REM and REM sleep.

Authors:  Michihiro Mieda; Emi Hasegawa; Yaz Y Kisanuki; Christopher M Sinton; Masashi Yanagisawa; Takeshi Sakurai
Journal:  J Neurosci       Date:  2011-04-27       Impact factor: 6.167

8.  Tuning arousal with optogenetic modulation of locus coeruleus neurons.

Authors:  Matthew E Carter; Ofer Yizhar; Sachiko Chikahisa; Hieu Nguyen; Antoine Adamantidis; Seiji Nishino; Karl Deisseroth; Luis de Lecea
Journal:  Nat Neurosci       Date:  2010-10-31       Impact factor: 24.884

9.  Pharmacogenetic modulation of orexin neurons alters sleep/wakefulness states in mice.

Authors:  Koh Sasaki; Mika Suzuki; Michihiro Mieda; Natsuko Tsujino; Bryan Roth; Takeshi Sakurai
Journal:  PLoS One       Date:  2011-05-27       Impact factor: 3.240

10.  Control of hypothalamic orexin neurons by acid and CO2.

Authors:  Rhîannan H Williams; Lise T Jensen; Alex Verkhratsky; Lars Fugger; Denis Burdakov
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-11       Impact factor: 11.205

View more
  13 in total

Review 1.  Exploring the Role of Orexinergic Neurons in Parkinson's Disease.

Authors:  Sachin Kumar; Tapan Behl; Aayush Sehgal; Sukhbir Singh; Neelam Sharma; Saurabh Bhatia; Ahmed Al-Harassi; Mohammed M Abdel-Daim; Simona Bungau
Journal:  Neurotox Res       Date:  2021-09-08       Impact factor: 3.911

2.  Local corticotropin releasing hormone (CRH) signals to its receptor CRHR1 during postnatal development of the mouse olfactory bulb.

Authors:  Isabella Garcia; Paramjit K Bhullar; Burak Tepe; Joshua Ortiz-Guzman; Longwen Huang; Alexander M Herman; Lesley Chaboub; Benjamin Deneen; Nicholas J Justice; Benjamin R Arenkiel
Journal:  Brain Struct Funct       Date:  2014-09-16       Impact factor: 3.270

Review 3.  Orexin-A controls sympathetic activity and eating behavior.

Authors:  Giovanni Messina; Carmine Dalia; Domenico Tafuri; Vincenzo Monda; Filomena Palmieri; Amelia Dato; Angelo Russo; Saverio De Blasio; Antonietta Messina; Vincenzo De Luca; Sergio Chieffi; Marcellino Monda
Journal:  Front Psychol       Date:  2014-09-08

Review 4.  Sleep-Wake Regulation and Its Impact on Working Memory Performance: The Role of Adenosine.

Authors:  Carolin Franziska Reichert; Micheline Maire; Christina Schmidt; Christian Cajochen
Journal:  Biology (Basel)       Date:  2016-02-05

Review 5.  Daily Fluctuation of Orexin Neuron Activity and Wiring: The Challenge of "Chronoconnectivity".

Authors:  Idris A Azeez; Federico Del Gallo; Luigia Cristino; Marina Bentivoglio
Journal:  Front Pharmacol       Date:  2018-09-25       Impact factor: 5.810

6.  The Orexin-A-Regulated Akt/mTOR Pathway Promotes Cell Proliferation Through Inhibiting Apoptosis in Pancreatic Cancer Cells.

Authors:  Linna Suo; Xiaocen Chang; Yuyan Zhao
Journal:  Front Endocrinol (Lausanne)       Date:  2018-10-31       Impact factor: 5.555

Review 7.  Mechanisms Responsible for Genetic Hypertension in Schlager BPH/2 Mice.

Authors:  Kristy L Jackson; Geoffrey A Head; Cindy Gueguen; Emily R Stevenson; Kyungjoon Lim; Francine Z Marques
Journal:  Front Physiol       Date:  2019-10-18       Impact factor: 4.566

Review 8.  An overview of the orexinergic system in different animal species.

Authors:  Idris A Azeez; Olumayowa O Igado; James O Olopade
Journal:  Metab Brain Dis       Date:  2021-07-05       Impact factor: 3.584

9.  The hypocretin/orexin antagonist almorexant promotes sleep without impairment of performance in rats.

Authors:  Stephen R Morairty; Alan J Wilk; Webster U Lincoln; Thomas C Neylan; Thomas S Kilduff
Journal:  Front Neurosci       Date:  2014-01-31       Impact factor: 4.677

10.  Formulation development for the orexin receptor antagonist almorexant: assessment in two clinical studies.

Authors:  Jasper Dingemanse; Martine Gehin; Hans Gabriel Cruz; Petra Hoever
Journal:  Drug Des Devel Ther       Date:  2014-04-28       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.